Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice.
| Image |  |
|---|---|
| Description | scientific article published on 28 June 2013 |
| Author/s |
author: Satoshi Teramukai |
| Publication date | June 28, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |